Approval · Notice of Compliance 20832 · 2018
FLUCONAZOLE INJECTION: Notice of Compliance 20832
Issued May 4, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20832
- Date
- May 4, 2018
- Company
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Revisions to the product monograph
- Canadian reference product
- DIFLUCAN (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUCONAZOLE INJECTION | Not yet assigned | — |
Medicinal ingredients
- FLUCONAZOLE 2 MG per ML